Results 1 to 10 of about 10,829,007 (362)

Cardiovascular manifestations in mast cell activation disease: key insights for cardiologists and angiologists [PDF]

open access: yesFrontiers in Cardiovascular Medicine
Mast cell activation disease is a genetic disease entity characterized by a very pronounced clinical symptomatology with potential manifestations in virtually every organ and tissue.
Wolfgang Taumann, Gerhard J. Molderings
doaj   +2 more sources

Mast Cells: A New Frontier for Cancer Immunotherapy

open access: yesCells, 2021
Mast cells are unique tissue-resident immune cells of the myeloid lineage that have long been implicated in the pathogenesis of allergic and autoimmune disorders. More recently, mast cells have been recognized as key orchestrators of anti-tumor immunity,
Jake N. Lichterman, Sangeetha M. Reddy
doaj   +2 more sources

Tumor-Derived Extracellular Vesicles Induce CCL18 Production by Mast Cells: A Possible Link to Angiogenesis

open access: yesCells, 2022
Mast cells (MCs) function as a component of the tumor microenvironment (TME) and have both pro- and anti-tumorigenic roles depending on the tumor type and its developmental stage. Several reports indicate the involvement of MCs in angiogenesis in the TME
Irit Shefler   +3 more
doaj   +1 more source

CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis

open access: yesFrontiers in Immunology, 2023
The HMC-1.2 human mast cell (huMC) line is often employed in the study of attributes of neoplastic huMCs as found in patients with mastocytosis and their sensitivity to interventional drugs in vitro and in vivo.
Geethani Bandara   +7 more
doaj   +1 more source

Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner with Further Support from JNK

open access: yesCells, 2021
Thymic stromal lymphopoietin (TSLP) is released by epithelial cells following disturbed homeostasis to act as “alarmin” and driver of Th2-immunity. Aberrant TSLP expression is a hallmark of atopic diseases, including atopic dermatitis (AD).
Magda Babina   +3 more
doaj   +1 more source

Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production

open access: yesHaematologica, 2020
Persistent dysregulation of IL-6 production and signaling have been implicated in the pathology of various cancers. In systemic mastocytosis, increased serum levels of IL-6 associate with disease severity and progression, although the mechanisms involved
Araceli Tobío   +9 more
doaj   +1 more source

The ingenious mast cell: Contemporary insights into mast cell behavior and function

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2020
Mast cells are (in)famous for their role in allergic diseases, but the physiological and pathophysiological roles of this ingenious cell are still not fully understood.
Joakim S. Dahlin   +5 more
semanticscholar   +1 more source

Mastocytosis-derived extracellular vesicles deliver miR-23a and miR-30a into pre-osteoblasts and prevent osteoblastogenesis and bone formation

open access: yesNature Communications, 2021
Osteoporosis and bone disease are common in patients with systemic mastocytosis. Here, the authors show that extracellular vesicles released by neoplastic mast cells of the patients block osteoblast differentiation and bone mineralization when injected ...
Do-Kyun Kim   +9 more
doaj   +1 more source

Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI‐mediated signaling

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2020
Short‐chain fatty acids (SCFAs) are fermented dietary components that regulate immune responses, promote colonic health, and suppress mast cell–mediated diseases.
Jelle Folkerts   +12 more
semanticscholar   +1 more source

Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins

open access: yesFrontiers in Immunology, 2021
Both, aberrant mast cell responses and complement activation contribute to allergic diseases. Since mast cells are highly responsive to C3a and C5a, while Interleukin-33 (IL-33) is a potent mast cell activator, we hypothesized that IL-33 critically ...
Peter W. West   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy